کاتتر ترومبولیز Viper ULTRA
یک فوق العاده کاتتر تزریق مخصوص مستقیم تحویل ترومبولیتیک، شامل چند سوراخه طراحی برای توزیع یکنواخت داروها در سراسر بخشهای بزرگ لخته.
The Viper® Ultrasonic Pharmacomechanical Thrombolysis System یک است کم تهاجمی device designed to dissolve thrombi by combining targeted ultrasonic waves with controlled tPA infusion. By thinning fibrin و increasing clot porosity, the system enables deeper drug penetration into the thrombus, thereby enhancing the efficacy of pharmacological therapy. This approach helps mitigate potential bleeding complications و preserves vessel integrity, offering a more refined, patient-centric strategy for acute thrombosis management.
Ultrasonic Wave Delivery
- Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
- Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
Pharmacomechanical Infusion
- tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
- Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
Gentle Mechanization
- Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
- Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.
- Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
- Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
- tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
- Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
- Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
- Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.
مشخصات محصول
| مشخصات | جزئیات / ارزش |
| نام محصول | کاتتر ترومبولیز Viper ULTRA |
| کاربرد مورد نظر | Catheter-directed infusion of thrombolytics in acute or subacute thrombus (peripheral, venous, or arterial) |
| طراحی کاتتر | Multi-hole distal segment for uniform drug dispersion, possible radiopaque marker at tip |
| مواد | Pebax/Polyamide shaft, potentially braided or reinforced |
| قطر بیرونی (F) | ~4–6F (depending on infusion lumen capacity) |
| طول کار | ~80–150 cm (varies by product code) |
| Infusion Ports | Distributed side ports over a defined segment for consistent thrombolytic delivery |
| سازگاری با گاید وایر | Typically 0.014” or 0.018” |
| استریل بودن | استریل، یکبار مصرف |
| ماندگاری | ~2–3 years if stored at 15–25 °C in sealed packaging |
| علائم بالینی | Thrombolytic infusion for DVT, peripheral arterial occlusions, possibly for intra-graft thrombosis |
| موارد منع مصرف | Highly calcified lesions, severe vessel tortuosity preventing safe passage, known device material allergies |
ماتریس مرتبسازی و اندازه
| قطر بیرونی (F) | طول کار (سانتی متر) | Infusion Segment (cm) | کد محصول | یادداشتها |
| 4F | 80 | 10 | VPR-4F-80-10 | Smaller OD for distal or small vessel usage |
| 4F | 120 | 15 | VPR-4F-120-15 | Longer shaft, moderate infusion segment |
| 5F | 80 | 10 | VPR-5F-80-10 | Slightly larger OD for heavier clot load |
| 5F | 120 | 20 | VPR-5F-120-20 | Extended length with longer infusion zone |
| 6F | 100 | 15 | VPR-6F-100-15 | Common size for multi-level peripheral lesions |
| 6F | 150 | 30 | VPR-6F-150-30 | Max length, extensive infusion segment |




